Abstract
Though Forkhead box P (FOXP) transcription factors comprising of FOXP1, FOXP2, FOXP3 and FOXP4 are involved in the embryonic development, immune disorders and cancer progression, the underlying function of FOXP3 targeting CD4 + CD25+ regulatory T (Treg) cells and the dual roles of FOXP proteins as an oncogene or a tumor suppressor are unclear and controversial in cancers to date. Thus, the present review highlighted research history, dual roles of FOXP proteins as a tumor suppressor or an oncogene, their molecular networks with other proteins and noncoding RNAs, cellular immunotherapy targeting FOXP3, and clinical implications in cancer progression.
Original language | English |
---|---|
Article number | 180 |
Journal | Molecular Cancer |
Volume | 18 |
Issue number | 1 |
DOIs | |
State | Published - 9 Dec 2019 |
Keywords
- Cellular immunotherapy
- Clinical implications and cancer progression
- FOXP proteins
- Molecular networks
- Noncoding RNAs